BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Closed|| Long (1Y)
Religare maintains buy on Sun Pharma
Religare has maintained "buy" call Sun Pharma for a target price of Rs 875. Sun Pharma shares are trading around 20 times its FY18 estimated earnings per share, which is the lower end of its historical valuation, said Religare.